TickerFactsScreenerDevelopers

Protalix BioTherapeutics, Inc. (PLX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $42.60M2009: $81.27M2010: $35.90M2011: $27.00M2012: $52.03M2013: $86.40M2014: $54.77M2015: $76.37M2016: $63.28M2017: $51.16M2018: $37.81M2019: $17.79M2020: $18.27M2021: $38.98M2022: $17.11M2023: $23.63M2024: $19.76M2025: $14.68M$14.68M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$14.68M-25.7%
2024$19.76M-16.4%
2023$23.63M+38.1%
2022$17.11M-56.1%
2021$38.98M+113.4%
2020$18.27M+2.7%
2019$17.79M-52.9%
2018$37.81M-26.1%
2017$51.16M-19.1%
2016$63.28M-17.1%
2015$76.37M+39.5%
2014$54.77M-36.6%
2013$86.40M+66.0%
2012$52.03M+92.7%
2011$27.00M-24.8%
2010$35.90M-55.8%
2009$81.27M+90.8%
2008$42.60M—